GMV g medical innovations holdings limited

Ann: Response to TMT Analytics Report, page-74

  1. 4,502 Posts.
    lightbulb Created with Sketch.  239
    re
    India/Taiwan deal (U$90m first year)

    Lets say,
    Once CFDA is in the bag,
    factory opens for business,
    Single deal, Taiwan/India LOC deal-terms are fixed & go unconditional.

    Then
    Primza Sensors sales (excluding other Primza MOUs, GPatch sales, & other services):

    Units, @A$150 ea

    Y1, 200'000 = $30m ( double T*T sales)
    Y2, 400'000 = $60m
    Y3, 600'000 = $90m


    Qn
    Can we conservatively say, 12 mth share price target

    = $1.85 to $2.20 * (based on Taiwan/India MOU, one deal).


    *Share price excludes valuations of:

    a.Other MOUs -- Shandong B, Beijing Silverlake, Greece/Cyprus, & USA WinolaLake,
    b.GPatch sales
    c.Other USA medical services


    Aimo
    Cheers
    G

    ~

    Ps
    Keep an eye on Xero annual 2017/8 financial report, expected soon
    ~
    Last edited by Glyco: 16/04/18
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.